Does IBALIZUMAB-UIYK Cause Dyspnoea? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Dyspnoea have been filed in association with IBALIZUMAB-UIYK. This represents 3.8% of all adverse event reports for IBALIZUMAB-UIYK.
16
Reports of Dyspnoea with IBALIZUMAB-UIYK
3.8%
of all IBALIZUMAB-UIYK reports
0
Deaths
9
Hospitalizations
How Dangerous Is Dyspnoea From IBALIZUMAB-UIYK?
Of the 16 reports, 9 (56.3%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IBALIZUMAB-UIYK. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does IBALIZUMAB-UIYK Cause?
Rash (40)
Product dose omission issue (37)
Viral load increased (37)
Drug ineffective (31)
Hospitalisation (30)
Diarrhoea (28)
Fatigue (28)
Pruritus (24)
Nausea (22)
Death (21)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which IBALIZUMAB-UIYK Alternatives Have Lower Dyspnoea Risk?
IBALIZUMAB-UIYK vs IBANDRONATE
IBALIZUMAB-UIYK vs IBANDRONIC ACID
IBALIZUMAB-UIYK vs IBERDOMIDE
IBALIZUMAB-UIYK vs IBREXAFUNGERP
IBALIZUMAB-UIYK vs IBRITUMOMAB TIUXETAN